scholarly article | Q13442814 |
P356 | DOI | 10.1038/ONC.2010.368 |
P698 | PubMed publication ID | 20818440 |
P50 | author | Simone Fulda | Q21264686 |
Edoardo Missiaglia | Q56426845 | ||
Kathryn Pritchard-Jones | Q56560148 | ||
Janet Shipley | Q60537989 | ||
P2093 | author name string | H Hahn | |
A Rosenberger | |||
A Zibat | |||
P2860 | cites work | Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion | Q21146049 |
PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group | Q28201860 | ||
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours | Q28206040 | ||
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis | Q29614405 | ||
Rhabdomyosarcoma--working out the pathways | Q33739291 | ||
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma | Q34019208 | ||
Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification | Q34108593 | ||
Hedgehog signalling in cancer formation and maintenance | Q34291589 | ||
Communicating with Hedgehogs | Q34407911 | ||
Gli and hedgehog in cancer: tumours, embryos and stem cells. | Q34665999 | ||
Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: a Children's Oncology Group study | Q36766818 | ||
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group | Q37071890 | ||
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. | Q37482716 | ||
Rhabdomyosarcoma in children | Q37485855 | ||
Effects of RAS on the genesis of embryonal rhabdomyosarcoma. | Q38301662 | ||
Increased expression of the hedgehog signaling pathway in pediatric solid malignancies | Q39740299 | ||
Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development | Q39880703 | ||
The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation | Q40233567 | ||
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas | Q40254065 | ||
Hedgehog signalling in prostate regeneration, neoplasia and metastasis | Q40516539 | ||
Expression profiling and identification of novel genes involved in myogenic differentiation. | Q40605368 | ||
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer | Q40664922 | ||
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449 | Q42031842 | ||
Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome | Q42455110 | ||
Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development | Q42486654 | ||
Medulloblastoma growth inhibition by hedgehog pathway blockade | Q44119270 | ||
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults | Q46118402 | ||
Pleiotropic effects of sonic hedgehog on muscle satellite cells. | Q46589313 | ||
Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma | Q48714160 | ||
Gli2 and Gli3 have redundant and context-dependent function in skeletal muscle formation. | Q52062326 | ||
Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. | Q52087418 | ||
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. | Q54434638 | ||
Targeting the Hedgehog pathway in cancer | Q79397666 | ||
Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry | Q82161721 | ||
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | alveolar rhabdomyosarcoma | Q4737958 |
P304 | page(s) | 6323-6330 | |
P577 | publication date | 2010-09-06 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma | |
P478 | volume | 29 |
Q36343292 | A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. |
Q28537996 | Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization |
Q36030949 | CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV |
Q41847776 | Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma |
Q37861207 | Cancer stem cells: the development of new cancer therapeutics. |
Q35602419 | Challenging issues in pediatric oncology |
Q37587392 | Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization |
Q50027091 | Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group |
Q90245956 | Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells |
Q36658489 | Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets |
Q92542126 | Current and Future Treatment Strategies for Rhabdomyosarcoma |
Q57492122 | Different Response of Mutant and Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors |
Q41917751 | Distinct cellular origin and genetic requirement of Hedgehog-Gli in postnatal rhabdomyosarcoma genesis |
Q41472801 | Dual degradation signals destruct GLI1: AMPK inhibits GLI1 through β-TrCP-mediated proteasome degradation |
Q37981253 | Ewing sarcoma: biology-based therapeutic perspectives |
Q38820614 | FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target |
Q28076296 | FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways |
Q35067950 | GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis |
Q36658484 | Genetics of Bladder Malignant Tumors in Childhood |
Q40803127 | Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines |
Q50116993 | Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. |
Q42323550 | Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma. |
Q58800972 | Hedgehog Signaling Pathway and Autophagy in Cancer |
Q35188293 | Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group. |
Q38834036 | Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells |
Q38396012 | Heparanase-1 and components of the hedgehog signalling pathway are increased in untreated alveolar orbital rhabdomyosarcoma |
Q54603571 | High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis. |
Q36002979 | Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1 |
Q38902471 | Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma |
Q41853105 | In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma |
Q37378867 | Inflammatory stress and sarcomagenesis: a vicious interplay |
Q47841646 | Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands. |
Q35832899 | Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line |
Q42153919 | Notch, wnt, and hedgehog pathways in rhabdomyosarcoma: from single pathways to an integrated network |
Q28512043 | Primary cilia control hedgehog signaling during muscle differentiation and are deregulated in rhabdomyosarcoma |
Q36142754 | Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems. |
Q38213666 | Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies |
Q95388147 | Rhabdomyosarcoma |
Q55041016 | SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function. |
Q58707604 | Soft Tissue Sarcoma Cancer Stem Cells: An Overview |
Q35756696 | Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics |
Q21285014 | Targeted therapies in sarcomas: challenging the challenge |
Q89667670 | Targeting cancer stem cell pathways for cancer therapy |
Q33586736 | Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma |
Q35987233 | Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened |
Q35971862 | The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis |
Q38671086 | The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma |
Q35655642 | The extracellular loops of Smoothened play a regulatory role in control of Hedgehog pathway activation |
Q38211082 | The role of inflammation in sarcoma |
Q34928886 | The role of mirk kinase in sarcomas |
Q37931268 | Therapeutic pipeline for soft-tissue sarcoma |
Q84166311 | Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice |
Q36975776 | Zebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis |
Search more.